Changes in hepatitis B vaccine perception in response to the COVID-19 pandemic: Development of the Shift in vaccine confidence (SVC) survey tool

The COVID-19 pandemic has disrupted access to, adherence to, and perceptions of routine vaccinations. We developed the Shift in Vaccine Confidence (SVC) survey tool to assess the impact of the pandemic on routine vaccinations, with a focus on the HBV vaccine, in Kinshasa, Democratic Republic of Cong...

Full description

Saved in:
Bibliographic Details
Published in:Vaccine 2023-01, Vol.41 (3), p.623-629
Main Authors: Boisson, Alix, Morgan, Camille E., Stover, Angela, Ngimbi, Patrick, Mbonze, Nana, Ntambua, Sarah, Matondo, Jolie, Parr, Jonathan B., Yotebieng, Marcel, Mwandagalirwa, Kashamuka, James, Linda, Mampunza, Samuel, Thompson, Peyton
Format: Article
Language:English
Subjects:
Coronaviruses
COVID-19
COVID-19 - prevention & control
COVID-19 vaccine
COVID-19 vaccines
Democratic Republic of the Congo
Disease transmission
Hepatitis B
Hepatitis B Vaccines
hepatitis B virus vaccine
Humans
Immunization
Infectious diseases
Interviews
Pandemics
Pandemics - prevention & control
Perception
Perceptions
Public health
Survey tool
Surveys
Vaccine hesitancy
Vaccines
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The COVID-19 pandemic has disrupted access to, adherence to, and perceptions of routine vaccinations. We developed the Shift in Vaccine Confidence (SVC) survey tool to assess the impact of the pandemic on routine vaccinations, with a focus on the HBV vaccine, in Kinshasa, Democratic Republic of Congo (DRC). This study describes the content validation steps we conducted to ensure the survey tool is meaningful to measure changes in vaccine confidence to regular immunization (HBV vaccine) due to the pandemic. Three rounds of stakeholder feedback from a DRC-based study team, content and measurement experts, and study participants allowed us to produce a measure with improved readability and clarity.
ISSN:0264-410X
1873-2518
1873-2518
DOI:10.1016/j.vaccine.2022.12.028